DefenCath: payments to doctors
Payments that named DefenCath as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $440K
- Providers
- 1,148
- Transactions
- 1,690
- Average per transaction
- $260
The per-transaction average — $260 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,148 providers the average total is $383, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Cormedix Inc. | $440,007 | 100.0% |